Cargando…
Transient Receptor Potential Channels and Botulinum Neurotoxins in Chronic Pain
Pain afflicts more than 1.5 billion people worldwide, with hundreds of millions suffering from unrelieved chronic pain. Despite widespread recognition of the importance of developing better interventions for the relief of chronic pain, little is known about the mechanisms underlying this condition....
Autores principales: | Go, Eun Jin, Ji, Jeongkyu, Kim, Yong Ho, Berta, Temugin, Park, Chul-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586451/ https://www.ncbi.nlm.nih.gov/pubmed/34776867 http://dx.doi.org/10.3389/fnmol.2021.772719 |
Ejemplares similares
-
Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice
por: Oehler, Beatrice, et al.
Publicado: (2022) -
Transient Receptor Potential Channel 4 Small-Molecule Inhibition Alleviates Migraine-Like Behavior in Mice
por: Cohen, Cinder Faith, et al.
Publicado: (2021) -
Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine
por: Cohen, Cinder Faith, et al.
Publicado: (2023) -
New botulinum neurotoxin constructs for treatment of chronic pain
por: Leese, Charlotte, et al.
Publicado: (2023) -
Unconventional Role of Caspase-6 in Spinal Microglia Activation and Chronic Pain
por: Berta, Temugin, et al.
Publicado: (2017)